AIP
VIR icon

Ameritas Investment Partners’s Vir Biotechnology VIR Stock Holding History

Ameritas Investment Partners’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
11,156
+3,770
+51% +$35.9K ﹤0.01% 1751
2026
Q1 		$66.2K Sell
7,386
-935
-11% -$7.45K ﹤0.01% 1925
2025
Q4 		$50.2K Hold
8,321
– – ﹤0.01% 2114
2025
Q3 		$47.5K Hold
8,321
– – ﹤0.01% 2165
2025
Q2 		$41.9K Hold
8,321
– – ﹤0.01% 2300
2025
Q1 		$53.9K Hold
8,321
– – ﹤0.01% 2062
2024
Q4 		$61.1K Hold
8,321
– – ﹤0.01% 2064
2024
Q3 		$62.3K Hold
8,321
– – ﹤0.01% 2066
2024
Q2 		$74.1K Hold
8,321
– – ﹤0.01% 1918
2024
Q1 		$84.3K Hold
8,321
– – ﹤0.01% 1849
2023
Q4 		$83.7K Hold
8,321
– – ﹤0.01% 1857
2023
Q3 		$78K Buy
8,321
+1,405
+20% +$20K ﹤0.01% 1826
2023
Q2 		$170K Buy
6,916
+1,113
+19% +$27.9K 0.01% 1242
2023
Q1 		$135K Hold
5,803
– – 0.01% 1327
2022
Q4 		$169K Buy
5,803
+364
+7% +$8.92K 0.01% 1248
2022
Q3 		$104K Hold
5,439
– – ﹤0.01% 1464
2022
Q2 		$138K Buy
5,439
+726
+15% +$16.9K 0.01% 1287
2022
Q1 		$121K Hold
4,713
– – ﹤0.01% 1510
2021
Q4 		$197K Hold
4,713
– – 0.01% 1247
2021
Q3 		$205K Hold
4,713
– – 0.01% 1185
2021
Q2 		$223K Buy
4,713
+355
+8% +$16.1K 0.01% 1165
2021
Q1 		$223K Sell
4,358
-208
-5% -$11.2K 0.01% 1139
2020
Q4 		$122K Hold
4,566
– – 0.01% 1455
2020
Q3 		$157K Buy
4,566
+476
+12% +$20.5K 0.01% 1167
2020
Q2 		$168K Buy
4,090
+3,470
+560% +$116K 0.01% 1092
2020
Q1 		$21K Hold
620
– – ﹤0.01% 2158
2019
Q4 		$8K Buy
+620
New +$8.31K ﹤0.01% 2813

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameritas Investment Partners's VIR Position: Q2 2026 in Review

Ameritas Investment Partners increased its Vir Biotechnology (VIR) stake by 51% in Q2 2026, buying an estimated $35.9K and bringing the position to 11,156 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Ameritas Investment Partners first reported a position in VIR in Q4 2019 and has held it in 27 quarters since. The position peaked at $223K in Q2 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Ameritas Investment Partners held 11,156 shares of Vir Biotechnology worth $114K as of Q2 2026.
  • Ameritas Investment Partners bought 3,770 Vir Biotechnology shares in Q2 2026, an estimated $35.9K.
  • Vir Biotechnology made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1751 holding.
  • Ameritas Investment Partners first reported a position in Vir Biotechnology in Q4 2019 and has held it in 27 quarters since.
  • Ameritas Investment Partners's Vir Biotechnology position peaked at $223K in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.